Anabolic Hormone Deficiencies in Heart Failure with Reduced or Preserved Ejection Fraction and Correlation with Plasma Total Antioxidant Capacity

Table 1

Echocardiographic parameters in the two subgroups of heart failure, with preserved or reduced ejection fraction (HFpEF and HFrEF, respectively).

	HFpEF	HFrEF
LV-EDV (ml)	48.6 ± 1	146 ± 13	<0.05
LV-ESV (ml)	31.1 ± 1.8	91 ± 10	<0.05
LV-PW (mm)	10.9 ± 0.6	10.6 ± 0.6	n.s.
E (mm/s)	575.3 ± 74.6	347 ± 152	n.s.
A (mm/s)	789.6 ± 63.3	334 ± 110.74	<0.05
EF (%)	55.7 ± 0.8	36.91 ± 2	<0.05
E/A	0.8 ± 0.1	1.10 ± 0.38	n.s.
E/e′	11.9 ± 1.2	12.42 ± 2.86	n.s.
LAV (ml)	86.4 ± 8.9	117.86 ± 12	<0.05
TAPSE (mm)	21.3 ± 0.9	19.5 ± 1.21	n.s.
SPAP (mmHg)	35.9 ± 2.4	42 ± 4.84	n.s.

LV-EDV = left ventricular end-diastolic volume; LV-ESV = left ventricular end-systolic volume; LV-PW = left ventricular posterior wall thickness; E = E wave; A = A wave; e′ = e′ wave; EF = ejection fraction; LAV = left atrial volume; TAPSE = tricuspid annular plane systolic excursion; SPAP = systolic pulmonary arterial pressure.